Wallace Biotechnologies Announces Deployment of Robolabs Autonomous Wet Labs to Scale Low-Cost Biological Testing and AI-Driven Clinical ModellingNEW YORK CITY, NY / ACCESS Newswire / August 5, 2026 / Wallace Biotechnologies announced the deployment of autonomous wet labs, branded Robolabs, designed to reduce the per-test cost of laboratory diagnostics by roughly 90 percent and to generate large-scale biological datasets intended for machine learning and model-driven clinical research.
